Your browser doesn't support javascript.
Impact of the COVID-19 pandemic on contact tracing of patients with pulmonary tuberculosis.
Godoy, Pere; Parrón, Ignasi; Barrabeig, Irene; Caylà, Joan A; Clotet, Laura; Follia, Núria; Carol, Monica; Orcau, Angels; Alsedà, Miquel; Ferrús, Gloria; Plans, Pere; Jane, Mireia; Millet, Joan-Pau; Domínguez, Angela.
  • Godoy P; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Parrón I; Institut de Recerca Biomédica de Lleida (IRBLleida), Lleida, Spain.
  • Barrabeig I; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Caylà JA; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Clotet L; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Follia N; Foundation of the Tuberculosis Research Unit of Barcelona, Barcelona, Spain.
  • Carol M; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Orcau A; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Alsedà M; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Ferrús G; Agència de Salut Pública de Barcelona, Barcelona, Spain.
  • Plans P; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Jane M; Institut de Recerca Biomédica de Lleida (IRBLleida), Lleida, Spain.
  • Millet JP; Agència de Salut Pública Catalunya, Barcelona, Spain.
  • Domínguez A; Agència de Salut Pública Catalunya, Barcelona, Spain.
Eur J Public Health ; 32(4): 643-647, 2022 08 01.
Article in English | MEDLINE | ID: covidwho-1758732
ABSTRACT

BACKGROUND:

The COVID-19 pandemic could have negative effects on tuberculosis (TB) control. The objective was to assess the impact of the pandemic in contact tracing, TB and latent tuberculosis infection (LTBI) in contacts of patients with pulmonary TB in Catalonia (Spain).

METHODS:

Contact tracing was carried out in cases of pulmonary TB detected during 14 months in the pre-pandemic period (1 January 2019 to 28 February 2020) and 14 months in the pandemic period (1 March 2020 to 30 April 2021). Contacts received the tuberculin skin test and/or interferon gamma release assay and it was determined whether they had TB or LTBI. Variables associated with TB or LTBI in contacts (study period and sociodemographic variables) were analyzed using adjusted odds ratio (aOR) and the 95% confidence intervals (95% CI).

RESULTS:

The pre-pandemic and pandemic periods showed, respectively 503 and 255 pulmonary TB reported cases (reduction of 50.7%); and 4676 and 1687 contacts studied (reduction of 36.1%). In these periods, the proportion of TB cases among the contacts was 1.9% (84/4307) and 2.2% (30/1381) (P = 0.608); and the proportion of LTBI was 25.3% (1090/4307) and 29.2% (403/1381) (P < 0.001). The pandemic period was associated to higher LTBI proportion (aOR = 1.3; 95% CI 1.1-1.5), taking into account the effect on LTBI of the other variables studied as sex, age, household contact and migrant status.

CONCLUSIONS:

COVID-19 is affecting TB control due to less exhaustive TB and LTBI case detection. An increase in LTBI was observed during the pandemic period. Efforts should be made to improve detection of TB and LTBI among contacts of TB cases.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / Tuberculosis, Pulmonary / Latent Tuberculosis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Eur J Public Health Journal subject: Epidemiology / Public Health Year: 2022 Document Type: Article Affiliation country: Eurpub

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / Tuberculosis, Pulmonary / Latent Tuberculosis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Eur J Public Health Journal subject: Epidemiology / Public Health Year: 2022 Document Type: Article Affiliation country: Eurpub